Longer term preplanned efficacy and safety analysis of abiraterone acetate + prednisone (AA + P) in patients (pts) with newly diagnosed high-risk metastatic castration-naïve prostate cancer (NDx-HR mCNPC) from the phase 3 LATITUDE trial

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 36; no. 15_suppl; p. 5023
Main Authors: Fizazi, Karim, Feyerabend, Susan, Matsubara, Nobuaki, Ozguroglu, Mustafa, Fein, Luis Enrique, Rodríguez Antolín, Alfredo, Alekseev, Boris Yakovlevich, Sulur, Giri, Protheroe, Andrew, De Porre, Peter, Li, Susan, Park, Youn C., Mundle, Suneel, Tran, Namphuong, Chi, Kim N.
Format: Journal Article
Language:English
Published: 20-05-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.5023